Gender disparities in multiple myeloma publications
Aala Dweik,
Hadeel Dweik,
Hira Mian,
Meera Mohan,
Carolina Schinke,
Samer Al Hadidi
Affiliations
Aala Dweik
Department of Medicine, Faculty of Medicine University of Jordan Amman Jordan
Hadeel Dweik
Department of Medicine, Faculty of Medicine University of Jordan Amman Jordan
Hira Mian
Department of Oncology McMaster University Hamilton Canada
Meera Mohan
Department of Internal Medicine Division of Hematology and Oncology Medical College of Wisconsin Milwaukee Wisconsin USA
Carolina Schinke
Department of Hematology and Oncology, Myeloma Center Winthrop P. Rockefeller Cancer Institute University of Arkansas for Medical Sciences Little Rock Arkansas USA
Samer Al Hadidi
Department of Hematology and Oncology, Myeloma Center Winthrop P. Rockefeller Cancer Institute University of Arkansas for Medical Sciences Little Rock Arkansas USA
Abstract Gender disparities exist in academia and are disproportionately affecting females. We conducted a cross‐sectional study to analyze gender disparities in multiple myeloma (MM) publications. A total of 679 publications with 8898 authorships were analyzed. The mean number of authors for females vs. males, per publication, was 4.4 and 8.7, respectively. Females constituted a third of the total authors. Female first authors, corresponding authors, and last/senior authors were 34%, 21%, and 18%, respectively. Note that, 17% of authors of clinical trial publications were females. Gender disparities in MM publications exist and are more obvious in the last/corresponding authorship. Efforts should be made to identify factors that contribute to these disparities and work to resolve them.
